Approval · Notice of Compliance 19008 · 2017
IMURAN: Notice of Compliance 19008
Issued February 24, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19008
- Date
- February 24, 2017
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
Products in this notice
Medicinal ingredients
- AZATHIOPRINE SODIUM 50 MG per VIAL
- AZATHIOPRINE 50 MG per TAB